Publication Listing for the MeSH term esophageal cancer. Found 21 abstracts
no paginationBakhos C, Patel S, Petrov R, Abbas A. Jejunostomy-technique and controversies. Journal of visualized surgery. 2019 Apr;5. PMCID: PMC6638548 |
Saxena R, Klochkova A, Murray MG, Kabir MF, Samad S, Beccari T, Gang J, Patel K, Hamilton KE, Whelan KA. Roles for Autophagy in Esophageal Carcinogenesis: Implications for Improving Patient Outcomes. Cancers. 2019 Oct 31;11(11). |
Dalton BG, Friedant AJ, Su S, Schatz TA, Ruth KJ, Scott WJ. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer. Journal of laparoendoscopic & advanced surgical techniques Part A. 2017 Dec;27(12):1279-83. |
Gerson JN, Skariah S, Denlinger CS, Astsaturov I. Perspectives of HER2-targeting in gastric and esophageal cancer. Expert opinion on investigational drugs. 2017 May;26(5):531-40. PMCID: PMC5563845 |
Malik F, Ali N, Durrani J, Mustafa SI, Denlinger C. Case series of multiple primary cancers in single individuals: diagnostic and therapeutic dilemmas. Journal of community hospital internal medicine perspectives. 2017 Oct;7(4):238-40. PMCID: PMC5637644 |
Shaikh T, Meyer JE, Horwitz EM. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Surg Oncol Clin N Am. 2017 Jul;26(3):405-29. PMCID: REVIEW |
Persson EC, Sewram V, Evans AA, London WT, Volkwyn Y, Shen YJ, Van Zyl JA, Chen G, Lin WY, Shephard GS, Taylor PR, Fan JH, Dawsey SM, Qiao YL, McGlynn KA, Abnet CC. Fumonisin B-1 and risk of hepatocellular carcinoma in two Chinese cohorts. Food and Chemical Toxicology. 2012 Mar;50(3-4):679-83. PMCID: PMC3299856 |
Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG. THE INFLUENCE OF TOTAL NODES EXAMINED, NUMBER OF POSITIVE NODES, AND LYMPH NODE RATIO ON SURVIVAL AFTER SURGICAL RESECTION AND ADJUVANT CHEMORADIATION FOR PANCREATIC CANCER: A SECONDARY ANALYSIS OF RTOG 9704. International Journal of Radiation Oncology Biology Physics. 2011 Dec;81(5):1328-35. PMCID: PMC3038247 |
Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer. Annals of Oncology. 2009 Jul;20(7):1242-8. PMCID: PMC2699385 |
Takaoka M, Kim SH, Okawa T, Michaylira CZ, Stairs DB, Johnstone CN, Andl CD, Rhoades B, Lee JJ, Klein-Szanto AJ, El-Deiry WS, Nakagawa H. IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms. Cancer Biology & Therapy. 2007 Apr;6(4):534-40. |
Henry LR, Goldberg M, Scott W, Konski A, Meropol NJ, Freedman G, Weiner LM, Watts P, Beard M, McLaughlin S, Cheng JD. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: A phase II report. ANNALS OF SURGICAL ONCOLOGY. 2006 Feb;13(2):214-20. |
Konski A, Doss M, Milestone B, Haluszka O, Hanlon A, Freedman G, Adler L. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. International Journal of Radiation Oncology Biology Physics. 2005 Mar 15;61(4):1123-8. |
Tanisada K, Teshima T, Ohno Y, Inoue T, Abe M, Ikeda H, Owen JB, Hanks GE, Masuda K, Honke Y, Japanese Patterns Care S. Patterns of care study quantitative evaluation of the quality of radiotherapy in Japan. Cancer. 2002 Jul;95(1):164-71. |
Tanisada K, Teshima T, Ikeda H, Abe M, Owen JB, Hanks GE, Yamashita T, Nishio M, Yamada S, Sakai K, Hiraoka M, Hirokawa Y, Oguchi M, Inoue T. A preliminary outcome analysis of the patterns of care study in Japan for esophageal cancer patients with special reference to age: Non surgery group. International Journal of Radiation Oncology Biology Physics. 2000 Mar 15;46(5):1223-33. |
Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ, Cheffetz S, Herlyn M. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Research. 1999 Oct;59(19):4876-81. |
Barnabas N, Moraes R, Calaf G, Estrada S, Russo J. Role of P53 in Mcf-10f Cell Immortalization and Chemically- Induced Neoplastic Transformation. International Journal of Oncology. 1995 Dec;7(6):1289-96. |
Fortunato L, Ridge JA. Surgical Palliation of Cancer .2. Surgical Palliative of Head and Neck-Cancer. Current Problems in Cancer. 1995 May;19(3):153-65. |
Yeh KA, Goldberg M. Surgical Palliation of Cancer .1. Palliative Surgery for Thoracic Malignancies. Current Problems in Cancer. 1995 May;19(3):130-52. |
Coia LR. The Use of Mitomycin in Esophageal Cancer. Oncology. 1993 Apr;50:53-62. |
Coia LR, Soffen EM, Schultheiss TE, Martin EE, Hanks GE. Swallowing Function in Patients with Esophageal Cancer Treated with Concurrent Radiation and Chemotherapy. Cancer. 1993 Jan 15;71(2):281-6. |
MeSH cloud from publications including the MeSH term esophageal cancer
esophageal cancer
radiotherapy
squamous-cell carcinoma
chemotherapy
therapy
radiation-therapy
stratification
carcinoma
trial
Patterns of Care Study
neoadjuvant chemoradiotherapy
adenocarcinoma
institution
cancer
radiation
management
LUNG-CANCER
cisplatin
trastuzumab
corn
esophagus
human-breast-cancer
GROWTH-FACTOR
randomized controlled-trial
esophageal carcinoma
FACTOR-I RECEPTOR
oral cavity
control
wild-type p53
percutaneous endoscopic gastrostomy
IGFBP-3
EPITHELIAL-CELLS
laparoscopic
junction
CANCER CELLS
laparoscopy
mitomycin-c
carcinoid tumors
Nodal ratio
nutritional-status
cardia
long-term survival
analysis
induction
positron emission tomography
PLUS CISPLATIN
chemoradiotherapy
ADVANCED SOLID TUMORS
pleural effusions
endoscopic ultrasound
fdg-pet
ras mutations
j-tube
therapy-oncology-group
intensity-modulated radiotherapy
high-grade dysplasia
oncology
quality assurance
primary liver-cancer
colon cancer
KERATINOCYTES
primary management
preoperative chemoradiation
IGF
phase-iii trial
curative resection
hair
lung-cancer
p53 gene
gastrostomy
massive hemoptysis
bronchogenic-carcinoma
ct
quantitative evaluation
trimodality
Oncology
DNA TOPOISOMERASE-I
ductal adenocarcinoma
FACTOR-BINDING PROTEIN-3
gene amplification
cell-cycle
pancreaticoduodenectomy
cdkn2 gene
gel-
surgery
human head
toxicity
ADJUVANT CHEMOTHERAPY
radical radiation-therapy
RANDOMIZED-TRIAL
2-STAGE DESIGNS
adenovirus-mediated transfer
complication
g(1) phase
ErbB2
mortality
cell
standard
transformation
cancer-cells
cycle
invitro
mitomycin
conformation polymorphism
organ preservation
intracavitary bleomycin
exposure
electrophoresis
mutant p53
endoscopic
jejunostomy
nd-yag laser
esophageal adenocarcinoma
p53
p16
mycotoxins
field cancerization
survival
TRANSGENIC MICE
Lymph node
Radiation therapy
ADVANCED ESOPHAGOGASTRIC CANCER
Her2
irinotecan
GASTROESOPHAGEAL ADENOCARCINOMA
prognostic-factors
computed-tomography
EXPRESSION
Malnutrition
neoadjuvant
3-dimensional conformal radiotherapy
TGF-BETA
haimen-city
Ras
gene-mutations
Pancreatic cancer
mammary epithelial-cells
gastric cancer
5-fluorouracil infusion
chemoradiation
extrapleural pneumonectomy
esophagectomy
tumor suppressor
Multiple cancers
follow-up
cervix
republic-of-china
extended lymphadenectomy
ADVANCED GASTRIC-CANCER
docetaxel